Interact to see
Advertisement
Advertisement
SVACX vs VIVIX
SVACX vs VIVIX Comparison
Open Charts SVACX vs VIVIX
Federated Hermes Strategic Value Div C
Price$6.49
Change+$0.06 (+0.93%)
VolumeN/A
Net Assets8.67B
SVACX vs VIVIX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
VS
SVACX vs. VIVIX commentary
Oct 19, 2025
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SVACX is a Hold and VIVIX is a Buy.
FUNDAMENTALS
Fundamentals
VIVIX has more cash in the bank: 208B vs. SVACX (8.67B). SVACX pays higher dividends than VIVIX: SVACX (2.22) vs VIVIX (2.09). SVACX was incepted earlier than VIVIX: SVACX (21 years) vs VIVIX (27 years). SVACX (1.93) is less costly to investors than VIVIX (0.04). SVACX is a more actively managed with annual turnover of: 35.00 vs. VIVIX (9.00). SVACX has a lower initial minimum investment than VIVIX: SVACX (1500) vs VIVIX (5000000). VIVIX annual gain was more profitable for investors over the last year : 4.64 vs. SVACX (4.02). VIVIX return over 5 years is better than : 71.78 vs. SVACX (58.00).
| SVACX | VIVIX | SVACX / VIVIX | |
| Total Expense Ratio | 1.87 | 0.04 | 4,675% |
| Annual Report Gross Expense Ratio | 1.93 | 0.04 | 4,825% |
| Fund Existence | 21 years | 27 years | - |
| Gain YTD | 11.052 | 9.748 | 113% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1500 | 5000000 | 0% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 8.67B | 208B | 4% |
| Annual Yield % from dividends | 2.22 | 2.09 | 106% |
| Returns for 1 year | 4.02 | 4.64 | 87% |
| Returns for 3 years | 25.70 | 42.98 | 60% |
| Returns for 5 years | 58.00 | 71.78 | 81% |
| Returns for 10 years | 34.50 | 129.40 | 27% |
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| JNGLX | 75.69 | 0.46 | +0.61% |
| Janus Henderson Global Life Sciences D | |||
| GMVAX | 16.47 | 0.04 | +0.24% |
| Goldman Sachs Small/Mid Cap Equity A | |||
| FBAFX | 39.01 | 0.04 | +0.10% |
| American Funds American Balanced 529-F-2 | |||
| SGQAX | 46.26 | -0.03 | -0.06% |
| DWS International Growth A | |||
| TPISX | 14.04 | -0.08 | -0.57% |
| Nuveen Quant Intl Small Cap Eq Premier | |||